2
Advanced Pharmacology Midterm Exam with accurate detailed || || || || || || ||
solutions
Nurse practitioner prescriptive authority is regulated by:
|| || || || || ||
a. The National Council of Sate Board of Nursing
|| || || || || || || ||
b. The State Board of Nursing for each state
|| || || || || || || ||
c. The U. S. Drug Enforcement Administration
|| || || || || ||
d. The State Board of Pharmacy - ✔✔b. The State Board of Nursing for each state
|| || || || || || || || || || || || || || ||
Eight Information needed for the prescription - ✔✔1. Date of prescribing;
|| || || || || || || || || || ||
2. Name of patient(s);
|| || || ||
3. Prescriber's name;
|| || ||
4. Name, strength, and dosage of drug or device;
|| || || || || || || || ||
5. Number of refills, if applicable;
|| || || || || ||
6. Quantity prescribed in weight, volume, or number of units;
|| || || || || || || || || ||
7. An indication of whether generic substitution has been authorized by the prescriber;
|| || || || || || || || || || || || ||
8. Any change or alteration made to the prescription dispensed on contact with the
|| || || || || || || || || || || || || ||
prescriber must show a clear audit trail.
|| || || || || ||
Three additional required information for controlled substances - ✔✔1. Address of the
|| || || || || || || || || || || ||
prescriber and patient; || || ||
2. The prescriber's DEA number;
|| || || || ||
3 Controlled prescriptions shall also comply with all requirements of federal and state
|| || || || || || || || || || || || ||
controlled substance laws. || ||
,2
Who oversees the APRN's prescribing of controlled substances?
|| || || || || || ||
a. The pharmaceutical board of the state
|| || || || || ||
b. The federal government (DEA)
|| || || ||
c. The practice protocols of the hospital
|| || || || || ||
d. Practice agreements - ✔✔b. The federal government (DEA)
|| || || || || || || ||
The USFDA regulates:
|| ||
a. Prescribing of drugs by medical doctors and nurse practitioners
|| || || || || || || || ||
b. The official labeling for all prescription and over-the-counter drugs
|| || || || || || || || ||
c. Off-label recommendations for prescribing
|| || || ||
d. Pharmaceutical educational offering - ✔✔b. The official labeling for all prescription and
|| || || || || || || || || || || || ||
over-the-counter drugs ||
Medication agreements or "Pain Medication Contracts" are recommended to be used:
|| || || || || || || || || ||
a. Universally for all prescribing for chronic pain
|| || || || || || ||
b. For patients who have repeated requests for pain medication
|| || || || || || || || ||
c. When you suspect a patient is exhibiting drug-seeking behavior
|| || || || || || || || ||
d. For patients with pain associated with malignancy - ✔✔a. Universally for all prescribing
|| || || || || || || || || || || || || ||
for chronic pain
|| ||
Anaphylactic shock is a: || || ||
a. Type I reaction, called immediate hypersensitivity reaction
|| || || || || || ||
b. Type II reaction, called cytotoxic hypersensitivity reaction
|| || || || || || ||
, 2
c. Type III reaction, called immune complex hypersensitivity
|| || || || || || ||
d. Type IV reaction, called delayed hypersensitivity reaction - ✔✔a. Type I reaction, called
|| || || || || || || || || || || || || ||
immediate hypersensitivity reaction || ||
The role of the nurse practitioner with regards to herbal medication is to:
|| || || || || || || || || || || ||
a. Maintain competence in the prescribing of common herbal remedies.
|| || || || || || || || ||
b. Recommend common over-the-counter herbs to patients.
|| || || || || ||
c. Educate patients and guide them to appropriate sources of care.
|| || || || || || || || || ||
d. Encourage patients to not use herbal therapy due to the documented dangers. - ✔✔c.
|| || || || || || || || || || || || || || ||
Educate patients and guide them to appropriate sources of care.
|| || || || || || || || ||
Prescribing for women during their childbearing years requires constant awareness of the
|| || || || || || || || || || || ||
possibility of: ||
a. High risk for developmental disorders in their infants
|| || || || || || || ||
b. Decreased risk for abuse during this time
|| || || || || || ||
c. Possible unknown pregnancy
|| || ||
d. Possibility of drug allergies - ✔✔c. Possible unknown pregnancy
|| || || || || || || || ||
Dysmenorrhea is one of the most common gynecological complaints in young women. The
|| || || || || || || || || || || || ||
first-line of drug treatment for this disorder is:
|| || || || || || ||
a. Oral contraceptive pills
|| || ||
b. Caffeine
||
c. NSAIDs
||
d. Aspirin - ✔✔c. NSAIDs
|| || || ||
Advanced Pharmacology Midterm Exam with accurate detailed || || || || || || ||
solutions
Nurse practitioner prescriptive authority is regulated by:
|| || || || || ||
a. The National Council of Sate Board of Nursing
|| || || || || || || ||
b. The State Board of Nursing for each state
|| || || || || || || ||
c. The U. S. Drug Enforcement Administration
|| || || || || ||
d. The State Board of Pharmacy - ✔✔b. The State Board of Nursing for each state
|| || || || || || || || || || || || || || ||
Eight Information needed for the prescription - ✔✔1. Date of prescribing;
|| || || || || || || || || || ||
2. Name of patient(s);
|| || || ||
3. Prescriber's name;
|| || ||
4. Name, strength, and dosage of drug or device;
|| || || || || || || || ||
5. Number of refills, if applicable;
|| || || || || ||
6. Quantity prescribed in weight, volume, or number of units;
|| || || || || || || || || ||
7. An indication of whether generic substitution has been authorized by the prescriber;
|| || || || || || || || || || || || ||
8. Any change or alteration made to the prescription dispensed on contact with the
|| || || || || || || || || || || || || ||
prescriber must show a clear audit trail.
|| || || || || ||
Three additional required information for controlled substances - ✔✔1. Address of the
|| || || || || || || || || || || ||
prescriber and patient; || || ||
2. The prescriber's DEA number;
|| || || || ||
3 Controlled prescriptions shall also comply with all requirements of federal and state
|| || || || || || || || || || || || ||
controlled substance laws. || ||
,2
Who oversees the APRN's prescribing of controlled substances?
|| || || || || || ||
a. The pharmaceutical board of the state
|| || || || || ||
b. The federal government (DEA)
|| || || ||
c. The practice protocols of the hospital
|| || || || || ||
d. Practice agreements - ✔✔b. The federal government (DEA)
|| || || || || || || ||
The USFDA regulates:
|| ||
a. Prescribing of drugs by medical doctors and nurse practitioners
|| || || || || || || || ||
b. The official labeling for all prescription and over-the-counter drugs
|| || || || || || || || ||
c. Off-label recommendations for prescribing
|| || || ||
d. Pharmaceutical educational offering - ✔✔b. The official labeling for all prescription and
|| || || || || || || || || || || || ||
over-the-counter drugs ||
Medication agreements or "Pain Medication Contracts" are recommended to be used:
|| || || || || || || || || ||
a. Universally for all prescribing for chronic pain
|| || || || || || ||
b. For patients who have repeated requests for pain medication
|| || || || || || || || ||
c. When you suspect a patient is exhibiting drug-seeking behavior
|| || || || || || || || ||
d. For patients with pain associated with malignancy - ✔✔a. Universally for all prescribing
|| || || || || || || || || || || || || ||
for chronic pain
|| ||
Anaphylactic shock is a: || || ||
a. Type I reaction, called immediate hypersensitivity reaction
|| || || || || || ||
b. Type II reaction, called cytotoxic hypersensitivity reaction
|| || || || || || ||
, 2
c. Type III reaction, called immune complex hypersensitivity
|| || || || || || ||
d. Type IV reaction, called delayed hypersensitivity reaction - ✔✔a. Type I reaction, called
|| || || || || || || || || || || || || ||
immediate hypersensitivity reaction || ||
The role of the nurse practitioner with regards to herbal medication is to:
|| || || || || || || || || || || ||
a. Maintain competence in the prescribing of common herbal remedies.
|| || || || || || || || ||
b. Recommend common over-the-counter herbs to patients.
|| || || || || ||
c. Educate patients and guide them to appropriate sources of care.
|| || || || || || || || || ||
d. Encourage patients to not use herbal therapy due to the documented dangers. - ✔✔c.
|| || || || || || || || || || || || || || ||
Educate patients and guide them to appropriate sources of care.
|| || || || || || || || ||
Prescribing for women during their childbearing years requires constant awareness of the
|| || || || || || || || || || || ||
possibility of: ||
a. High risk for developmental disorders in their infants
|| || || || || || || ||
b. Decreased risk for abuse during this time
|| || || || || || ||
c. Possible unknown pregnancy
|| || ||
d. Possibility of drug allergies - ✔✔c. Possible unknown pregnancy
|| || || || || || || || ||
Dysmenorrhea is one of the most common gynecological complaints in young women. The
|| || || || || || || || || || || || ||
first-line of drug treatment for this disorder is:
|| || || || || || ||
a. Oral contraceptive pills
|| || ||
b. Caffeine
||
c. NSAIDs
||
d. Aspirin - ✔✔c. NSAIDs
|| || || ||
